Thrive Bioscience

Thrive Bioscience is dedicated to advancing live cell biology through innovative imaging and analytics solutions, providing essential tools for academic and commercial research in cellular and molecular biology. Founded in 2014, Thrive Bioscience specializes in developing advanced imaging solutions for live cell biology research. Based in Beverly, US, the company has undergone no significant pivots. It was co-founded by Thomas Forest Farb, who has a history in the biotechnology sector.

Thrive Bioscience raised USD 2. 18 mn in its latest funding round in December 2015, which also marks the total amount raised. Thrive Bioscience specializes in the development and provision of advanced imaging and analytics solutions for live cell biology research. Its core product offerings include the CellAssist Family of Systems, featuring the environmentally-controlled CellAssist Benchtop Imager and the automated CellAssist 50 System.

The CellAssist Benchtop Imager allows for imaging of single cell culture plates using various technologies and supports different plate formats. The CellAssist 50 System enhances functionality with fully automated time-series imaging for up to 50 plates. These products cater to the needs of academic institutions and biotech firms, and are distributed primarily across North America, Europe, and parts of Asia. Thrive Bioscience generates revenue through the direct sale of its products, including the CellAssist Benchtop Imager and CellAssist 50 System, alongside associated software solutions.

Clients can purchase these systems outright or opt for subscription-based software services. The company's pricing structure accommodates various budgets, supporting both large and small research initiatives. Additionally, Thrive Bioscience collaborates with research institutions to further enhance its market presence. Thrive Bioscience plans to enhance its product line with the introduction of new imaging solutions designed for specific research applications over the next few years.

The company is targeting expansion into European and Asian markets by 2025, leveraging recent funding of USD 2. 18 mn to bolster these initiatives. This funding will support product development and marketing efforts to reach a broader client base in the global research community.